trending Market Intelligence /marketintelligence/en/news-insights/trending/RxEXLZWS76CsWfsVj6oNsA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Nuvectra to sell animal research related medical device unit for $5M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Nuvectra to sell animal research related medical device unit for $5M

Medical device maker Nuvectra Corp. agreed to sell its wholly owned unit, NeuroNexus Technologies Inc., to NEL Group Inc. for $5 million in cash.

NeuroNexus manufactures devices for conducting brain-related clinical research in animals.

NEL Group, which entered the sale agreement with Nuvectra effective Dec. 31, 2018, is affiliated with certain former employees of NeuroNexus.

Plano, Texas-based Nuvectra makes a neurostimulation device to treat chronic intractable pain of the trunk and limbs.

The divestiture will help the company focus resources on its neuromodulation technology, which is being developed to treat overactive bladder and Parkinson's disease, said Nuvectra CEO Scott Drees.